Synthaverse S.A. (WSE:SVE)
Poland flag Poland · Delayed Price · Currency is PLN
2.600
-0.010 (-0.38%)
Nov 4, 2026, 12:58 PM CET

Synthaverse Revenue

Synthaverse had revenue of 12.85M PLN in the quarter ending June 30, 2026, with 104.47% growth. This brings the company's total for the last twelve months to 48.76M, down -21.82% year-over-year. In the year 2025, Synthaverse had annual revenue of 42.01M, down -41.45%. That makes Synthaverse the 36,373rd largest company in the world by revenue and 322nd in Poland.

Revenue (ttm)
48.76M
Revenue Growth
-21.82%
P/S Ratio
4.07
Revenue / Employee
227.84K
Employees
214
Market Cap
197.65M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • BCG Segment 27.04M 64.4%
  • Traditional Segment 14.97M 35.6%

By Geography

Chart
  • Poland 16.22M 38.6%
  • Other Countries 13.93M 33.2%
  • European Union 11.85M 28.2%
Fiscal year ended Dec 31, 2025 See the full Synthaverse breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202542.01M-29.75M-41.45%
Dec 31, 202471.76M13.15M22.44%
Dec 31, 202358.61M8.22M16.32%
Dec 31, 202250.38M9.23M22.43%
Dec 31, 202141.15M996.00K2.48%
Dec 31, 202040.16M1.05M2.69%
Dec 31, 201939.11M6.81M21.10%
Dec 31, 201832.29M889.00K2.83%
Dec 31, 201731.40M-4.94M-13.58%
Dec 31, 201636.34M-6.25M-14.67%
Dec 31, 201542.59M9.01M26.84%
Dec 31, 201433.58M599.00K1.82%
Dec 31, 201332.98M-3.78M-10.28%
Dec 31, 201236.76M-3.37M-8.40%
Dec 31, 201140.13M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BIOTON257.23M
Ryvu Therapeutics83.94M
Mabion17.61M
Read-Gene16.66M
Molecure6.52M
Urteste2.77M
NanoGroup2.37M
Captor Therapeutics Spolka Akcyjna2.01M
Revenue Rankings